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 i  
ABSTRACT 
Understanding how adherence affects outcomes is crucial when developing and assigning 
interventions.  However, interventions are often evaluated by conducting randomized 
experiments and estimating intent-to-treat effects, which ignore actual treatment received.  
Dose-response effects can supplement intent-to-treat effects when participants are offered 
the full dose but many only receive a partial dose due to nonadherence.  Using these data, 
we can estimate the magnitude of the treatment effect at different levels of adherence, 
which serve as a proxy for different levels of treatment.  In this dissertation, I conducted 
Monte Carlo simulations to evaluate when linear dose-response effects can be accurately 
and precisely estimated in randomized experiments comparing a no-treatment control 
condition to a treatment condition with partial adherence.  Specifically, I evaluated the 
performance of confounder adjustment and instrumental variable methods when their 
assumptions were met (Study 1) and when their assumptions were violated (Study 2).  In 
Study 1, the confounder adjustment and instrumental variable methods provided unbiased 
estimates of the dose-response effect across sample sizes (200, 500, 2,000) and adherence 
distributions (uniform, right skewed, left skewed).  The adherence distribution affected 
power for the instrumental variable method.  In Study 2, the confounder adjustment 
method provided unbiased or minimally biased estimates of the dose-response effect 
under no or weak (but not moderate or strong) unobserved confounding.  The 
instrumental variable method provided extremely biased estimates of the dose-response 
effect under violations of the exclusion restriction (no direct effect of treatment 
assignment on the outcome), though less severe violations of the exclusion restriction 
should be investigated. 
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Nonadherence is pervasive in medicine, pharmacology, and psychology and 
substantially impacts public health.  Ignoring medical advice leads to morbidity, 
mortality, and avoidable medical costs, yet between 20% and 30% of prescribed 
medications are never filled and about half of medications for chronic diseases are not 
taken as prescribed (Bosworth, 2012).  Adhering to recommended behaviors (e.g., dietary 
modifications) can be even more challenging, and such behaviors account for 
approximately 40% of the risk associated with preventable premature deaths in the 
United States (National Institutes of Health, 2015).  Similarly, psychotherapy is often 
refused or ended prematurely, such that existing mental health problems may persist or 
worsen.  Based on a national database of 9,173 patients with various diagnoses, 3,101 
patients (33.8%) only attended one session of psychotherapy and most of the remaining 
6,072 patients attended fewer than five sessions (Hansen, Lambert, & Forman, 2002).  
These attendance rates fall far below the 13 to 18 sessions expected to be necessary for 
half of patients to improve (Hansen et al., 2002), and many more referred patients never 
attend a session. 
 Understanding how adherence affects outcomes is crucial when developing and 
assigning interventions.  However, interventions are often evaluated by conducting 
randomized experiments and estimating intent-to-treat effects, which ignore actual 
treatment received.  Dose-response effects can supplement intent-to-treat effects when 
participants are offered the full dose but many only receive a partial dose due to 
nonadherence.  By estimating the magnitude of the treatment effect at different levels of 
adherence (a proxy for different levels of treatment), dose-response effects can enhance 
our understanding of the treatment’s efficacy and potentially improve the generalizability 
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of the results.  In this dissertation, I conduct Monte Carlo simulations to examine when 
linear dose-response effects can be accurately and precisely estimated in randomized 
experiments comparing a no-treatment control condition to a treatment condition with 
partial adherence. 
 The remainder of this dissertation is organized as follows.  I first review the 
potential outcomes framework for causal inference.  I then introduce intent-to-treat 
effects and alternatives in the presence of nonadherence.  Whereas many alternatives 
require a binary measure of adherence or dichotomization of a discrete or continuous 
measure of adherence, dose-response estimation relies on partial adherence.  I describe 
two methods for estimating dose-response effects in randomized experiments with no 
measure of adherence in the control condition and a discrete or continuous measure of 
adherence in the treatment condition.  Finally, I conduct two simulation studies to 
evaluate the performance of these methods when their assumptions are met and when 
their assumptions are violated. 
Potential Outcomes Framework for Causal Inference 
In the potential outcomes framework for causal inference (Rubin, 1974, 1977, 
1978, 2005; Imbens & Rubin, 2015), the treatment effect for unit 𝑖 is defined as the 
difference between unit 𝑖’s response in the treatment condition, denoted 𝑌𝑖(𝑍 = 1) or 
𝑌𝑖(1), and its response in the control condition, denoted 𝑌𝑖(𝑍 = 0) or 𝑌𝑖(0): 
 𝑌𝑖(1) − 𝑌𝑖(0). (1) 
𝑌𝑖(1) and 𝑌𝑖(0) are referred to as unit 𝑖’s potential outcomes because only one will 
ultimately be realized and possibly observed.  Because we cannot observe 𝑌𝑖(1) and 
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𝑌𝑖(0) on the same unit (e.g., a single participant at a given time; Holland, 1986), our 
focus shifts from the unit’s treatment effect to the average treatment effect: 
 ATE = E[𝑌𝑖(1) − 𝑌𝑖(0)] = E[𝑌𝑖(1)] − E[𝑌𝑖(0)]. (2) 
To define the average treatment effect, three assumptions are necessary: consistency, 
stable unit treatment value assumption (SUTVA), and ignorable treatment assignment.  
Consistency states that a unit’s potential outcome under the treatment it actually received 
equals its observed outcome.  Letting 𝑌𝑖 denote unit 𝑖’s observed outcome, 𝑌𝑖 = 𝑌𝑖(1) if 
unit 𝑖 were in the treatment condition and 𝑌𝑖 = 𝑌𝑖(0) if unit 𝑖 were in the control 
condition. 
SUTVA ensures that each unit has only one potential outcome in the treatment 
condition and one potential outcome in the control condition.  SUTVA combines the no-
interference assumption that one unit’s treatment assignment does not affect another 
unit’s potential outcomes (Cox, 1958) with the assumption of no hidden variations of 
treatments (Rubin, 2010).
1
  Interference may occur in group-based interventions, such as 
when a participant’s engagement in the intervention depends on other members of the 
group.  Hidden variations of treatments may exist when interventions are delivered across 
multiple sites or by multiple clinicians or physicians.  Ensuring that the two components 
of SUTVA (no interference across units and no hidden variations of treatments) are met 
is best achieved through research design.  However, if SUTVA does not hold for the 
                                                 
1
 VanderWeele (2009) formalized the weaker assumption of treatment-variation irrelevance, meaning 
variations of the treatment may exist but all result in the same potential outcome for each unit.  Imbens and 
Rubin (2015) clarified that SUTVA does not require the treatment to be identical across all units.  Rather, 
SUTVA states that variations of the treatment cannot alter any unit’s potential outcome (p. 12). 
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outcome of interest, the set of represented treatments may be redefined to include 
previously hidden variations of treatments (Imbens & Rubin, 2015). 
Ignorable treatment assignment states that treatment assignment is independent of 
potential outcomes.  That is, treatment assignment is independent of the set of outcomes 
that would have been realized (though not necessarily observed) if all units had been in 
the treatment condition and the set of outcomes that would have been realized (though 
not necessarily observed) if all units had been in the control condition.  Successful 
randomization provides strong ignorability, or independence of treatment assignment and 
potential outcomes and independence of treatment assignment and all baseline covariates 
(whether measured or unmeasured).  Under strong ignorability, participants in the 
treatment and control conditions are equivalent, on average, at baseline and should thus 
only differ based on application of the treatment under investigation.  Although strong 
ignorability is not required to define the average treatment effect, achieving ignorability 
is difficult without randomization. 
Directly comparing the observed average outcome in the treatment condition and 
the observed average outcome in the control condition yields a causally valid estimate of 
the average treatment effect given that consistency, SUTVA, and ignorable treatment 
assignment hold; all units fully adhere to their assigned treatment; and all units’ treatment 
assignment and outcome are observed (Sagarin, West, Ratnikov, Homan, Ritchie, & 
Hansen, 2014).  However, nonadherence complicates the estimation of the average 
treatment effect and can compromise our ability to draw causal inferences.  The co-
occurrence of nonadherence and missing data is beyond the scope of this dissertation but 
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serves as a potential topic for future research.  The remainder of this dissertation assumes 
complete data. 
Overview of Nonadherence 
Nonadherence occurs when participants’ received treatment differs from their 
assigned treatment.  For example, nonadherence would occur if a participant failed to 
attend all of the required sessions in a multisession intervention, did not receive a 
vaccination after being encouraged to do so, or only partially adhered to a prescribed 
drug regimen.  Typically adherence is nonignorable, or related to participants’ potential 
outcomes.  Meier (1991) outlined three conditions under which adherence may be 
nonignorable.  First, characteristics of the participants may affect both adherence and the 
outcome, which he termed selection effects.  For example, participants’ baseline risk may 
predict both attendance and the outcome in a multisession intervention.  Second, 
characteristics of the treatment may lead to nonadherence, such as negative side effects 
from a prescribed drug regimen.  Finally, the outcome may cause changes in adherence.  
For example, participants with substance use problems who relapse may skip sessions of 
an intervention to avoid reprimand (West & Sagarin, 2000).  In practice, the processes 
leading to nonadherence are often complex, and these processes may interact, vary across 
conditions, or vary across participants in the same condition. 
The intent-to-treat method compares the observed average outcome of 
participants assigned to the treatment condition to that of participants assigned to the 
control condition, regardless of actual treatment received: 
 ITT = E[𝑌𝑖|𝑍𝑖 = 1] − E[𝑌𝑖|𝑍𝑖 = 0] (3) 
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where 𝑌𝑖 is the outcome and 𝑍𝑖 is treatment assignment (1 = treatment, 0 = control).  The 
intent-to-treat effect is a causally valid estimate of the average effect of treatment 
assignment, not treatment received.  Because treatment received is disregarded, the 
intent-to-treat effect conflates treatment efficacy with adherence (Sheiner & Rubin, 
1995).  Thus, when the magnitude of the intent-to-treat effect is lower than expected, we 
may question whether this results from an inefficacious treatment or from an efficacious 
treatment being diluted by nonadherence (Meier, 1991).  Overestimation can also occur if 
the treatment effect is not constant across participants and those who refuse or 
discontinue the treatment would have experienced iatrogenic effects (West & Sagarin, 
2000). 
 Generalization of the intent-to-treat effect assumes that the adherence pattern 
observed in the randomized experiment will be identical to the adherence pattern for a 
large-scale implementation of the intervention (Robins & Greenland, 1996), which may 
be implausible.  Participants who are selected and agree to partake in randomized 
experiments may be more motivated to adhere than the typical member of the population.  
High levels of monitoring and greater support for the treatment regimen may also 
promote greater adherence in randomized experiments.  Alternatively, a proven treatment 
or a different delivery method may elicit greater adherence (Sommer & Zeger, 1991; 
Robins & Greenland, 1996; Goetghebeur & Shapiro, 1996). 
Alternatives to Intent-to-Treat 
 To investigate the average effect of treatment received, alternatives to intent-to-
treat have been proposed in the presence of nonadherence (see Sagarin et al., 2014 for a 
review).  Many alternatives require a binary measure of adherence (e.g., receiving a 
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seasonal influenza vaccination or not) or dichotomization of a discrete or continuous 
measure of adherence.  However, decisions about how to dichotomize a discrete or 
continuous measure of adherence are often arbitrary and data-driven.  Dichotomization is 
also “rarely justified from either a conceptual or statistical perspective” (MacCallum, 
Zhang, Preacher, & Rucker, 2002, p. 20).  First, dichotomization distorts differences in 
adherence across participants.  For example, suppose that adherence is defined as 
attending at least seven out of ten sessions.  Although we may view a participant who 
attended six sessions as being more similar to a participant who attended seven sessions 
than to a participant who never attended, the participant who attended six sessions would 
be grouped with the participant who never attended.  Second, dichotomization leads to 
loss of information and lower measurement reliability (MacCallum et al., 2002).  Third, 
dichotomization attenuates bivariate associations.  Finally, nonlinear associations cannot 
be investigated given that adherence has only two possible values.  Because adherence 
often cannot reasonably be characterized as “all-or-none,” this dissertation focuses on 
partial adherence in randomized experiments. 
Dose-Response Effect 
 The ideal experimental design for understanding the impact of dose on outcomes 
would involve randomly assigning participants to receive different doses of the treatment 
and then ensuring that all participants are 100% adherent.  However, this experimental 
design is typically infeasible—withholding the full dose may be unethical and 100% 
adherence may be unachievable or impractical.  More commonly, participants are offered 
the full dose but many only receive a partial dose due to nonadherence.  Using these data, 
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we can estimate the magnitude of the treatment effect at different levels of adherence, 
which serve as a proxy for different levels of treatment. 
 Some methods for estimating dose-response effects require measures of 
adherence in both the treatment and control conditions (e.g., Holland, 1988; Efron & 
Feldman, 1991; Jin & Rubin, 2008).  With these methods, the outcomes of participants 
assigned to one treatment are compared to those of similarly adherent participants 
assigned to the other treatment.  However, assumptions about how adherence to one 
treatment relates to adherence to the other treatment may be difficult to justify, and 
adherence across different forms of treatment may not be comparable (e.g., medication 
management versus psychotherapy for children with attention-deficit hyperactivity 
disorder, MTA Cooperative Group, 1999; see Cooper & Richardson, 1986 for a 
discussion of unfair comparisons).  No-treatment and literature control conditions also 
limit the applicability of these methods.  In this dissertation, I examine confounder 
adjustment and instrumental variable methods for estimating linear dose-response effects 
in randomized experiments comparing a no-treatment control condition to a treatment 
condition with partial adherence.  The confounder adjustment and instrumental variable 
methods are much more applicable to psychological research because they do not require 
a measure of adherence in the control condition. 
Confounder Adjustment Method 
To estimate dose-response effects in randomized experiments with partial 
adherence, researchers commonly regress the outcome on adherence using data from only 
those participants in the treatment condition.  Most models assume a linear association 
between adherence and the outcome, though attempts have been made to allow for a 
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nonlinear association (e.g., using regression splines; Ramsay, 1988).  Regardless of the 
specified functional form, causal inferences about the dose-response effect may be 
difficult to justify due to selection effects. 
 To illustrate, consider the effectiveness trial of the New Beginnings Program, a 
preventive intervention designed to reduce mental health problems and substance use in 
children following their parents’ divorce or separation (Sandler et al., 2017).  Of the 477 
parents randomized to the ten-session treatment condition, 111 (23.3%) never attended, 
309 (64.8%) attended between one and nine sessions, and 57 (11.9%) attended all ten 
sessions.  Adherence (here defined as attendance) was likely nonignorable.  For example, 
mothers who reported greater conflict with the other parent at baseline were more likely 
to drop out of the intervention early than sustain attendance (Mauricio et al., 2017), and 
interparental conflict was related to outcomes of interest such as children’s mental health 
problems.  Observing a negative association between number of sessions attended and 
children’s mental health problems at posttest may be due to receiving more of the 
treatment, but it may also be due to interparental conflict confounding the association 
between number of sessions attended and children’s mental health problems (see 
Appendix A for a description of omitted variable bias in equations). 
 The confounder adjustment method requires the following assumptions to draw 
valid causal inferences about the dose-response effect (see Table 1 for a summary). 
1. Consistency states that a participant’s potential outcome under the dose actually 
received equals the observed outcome. 
2. The stable unit treatment value assumption states that there is no interference 
across participants and no hidden variations of treatments. 
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3. Positivity states that all participants have a nonzero probability of receiving each 
dose. 
4. The adherence level is measured without error. 
5. The adherence level and potential outcomes are conditionally independent.  That 
is, the adherence level must be ignorable conditional on the baseline covariates 
(confounders).
2
  This assumption implies that all of the confounders are measured 
without error. 
6. The covariate distributions for participants who received dose 𝑑 overlap with the 
covariate distributions for participants who received dose 𝑑′ where 𝑑 ≠ 𝑑′. 
7. The functional form of the dose-response curve and the relations between the 
baseline covariates and outcome are correctly specified. 
To satisfy Assumption 5, all baseline covariates that theoretically relate to both adherence 
and the outcome (confounders) must be included in the model as follows: 
 𝑌𝑖 = 𝑏0 + 𝑏1𝐷𝑖 +∑𝑏(𝑗+1)𝑋𝑗𝑖
𝑘
𝑗=1
+ 𝜀𝑖 (4) 
where 𝑌𝑖 is the outcome; 𝐷𝑖 is treatment received (dose); 𝑋1𝑖, 𝑋2𝑖,…, 𝑋𝑘𝑖 are baseline 
covariates; and 𝑖 = 1, 2, … , 𝑛𝑇 indexes the 𝑛𝑇 participants in the treatment condition.
3
  In 
the earlier example, children’s mental health problems would be regressed on number of 
sessions attended, baseline interparental conflict, and any other baseline covariates 
believed to be related to both number of sessions attended and children’s mental health 
problems.  When all confounders are perfectly measured and included in Equation 4 (and 
                                                 
2
 This assumption is sometimes referred to as selection on observables. 
3
 This dissertation focuses on confounders that are not influenced by the treatment. 
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all other assumptions outlined above are met), 𝑏1 allows for causal inferences about the 
average linear effect of receiving more of the treatment.  However, when some, but not 
all, confounders are observed, conditioning on an observed confounder can increase or 
decrease bias (Kenny, 2004; Clarke, Kenkel, & Rueda, 2016).  For example, if an 
observed confounder and an unobserved confounder have countervailing effects (i.e., one 
induces positive bias and the other induces negative bias), then conditioning on the 
observed confounder can increase bias.  Because the population model for 𝑌𝑖 is unknown, 
theory should guide which baseline covariates to include in Equation 4 (but see Mayer, 
Thoemmes, Rose, Steyer, & West, 2014). 
 Assumption 6 may also be difficult to justify in practice.  Diagnosing overlap 
becomes challenging with more than one or two confounders (Schafer & Kang, 2008), 
yet more than one or two confounders can easily exist.  Without sufficient overlap, 
ordinary least squares (OLS) estimation extrapolates beyond the observed data while 
relying heavily on the specified functional form.
4
  This extrapolation can lead to biased 
and unstable parameter estimates. 
Instrumental Variable Method 
 Unlike the confounder adjustment method, the instrumental variable method for 
estimating dose-response effects uses data from participants in both the treatment and 
control conditions and allows for unobserved confounding between adherence and the 
outcome.  The instrumental variable method relies on the existence of one or more so-
                                                 
4
 When adherence is discrete and has only a few possible values, propensity score adjustment can be used 
to reduce a large set of baseline covariates to a one-number summary, which helps diagnose overlap and 
avoid extrapolation beyond the observed data (Foster, 2003; McCaffrey et al., 2013).  However, achieving 
balance across participants with different levels of adherence may be difficult without a very large sample 
size. 
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called instruments that (1) cause treatment actually received, (2) only affect the outcome 
via treatment actually received (referred to as the exclusion restriction), and (3) do not 
share common causes with the outcome (Hernán & Robins, 2006).  In most randomized 
experiments, treatment assignment serves as an excellent instrument because it causes 
treatment actually received (Condition 1) and does not share common causes with the 
outcome with successful randomization (Condition 3); Condition 2 is usually the only 
condition at risk for failure. 
 Dunn and Bentall (2007), Maracy and Dunn (2011), and Ginestet, Emsley, and 
Landau (2017) described instrumental variable methods for estimating dose-response 
effects based on the potential outcomes framework.  Letting 𝑍𝑖 denote treatment 
assignment (1 = treatment, 0 = control), 𝑌𝑖(𝑧) denote participant 𝑖’s potential outcome if 
assigned to treatment 𝑧, and 𝐷𝑖(𝑧) ≥ 0 denote participant 𝑖’s potential dose if assigned to 
treatment 𝑧, they relied on the following assumptions (see Table 1 for a summary).5 
1. Consistency states that 𝐷𝑖 = 𝐷𝑖(z) and 𝑌𝑖 = 𝑌𝑖(𝑧) where 𝐷𝑖 and 𝑌𝑖 denote 
participant 𝑖’s observed dose and outcome, respectively. 
2. The stable unit treatment value assumption states that there is no interference 
across participants and no hidden variations of treatments.  This assumption 
ensures that each participant has only one value of 𝐷𝑖(0), 𝐷𝑖(1), 𝑌𝑖(0), and 𝑌𝑖(1). 
3. Participants are randomly assigned to the treatment and control conditions. 
                                                 
5
 The notation 𝑌𝑖(𝑧) is consistent with Ginestet et al. (2017), though these authors used 𝑅𝑖 instead of 𝑍𝑖 to 
denote treatment assignment.  The notation 𝑌𝑖(𝑧, 𝐷𝑖(𝑧)) has been used elsewhere (e.g., Imai, Keele, & 
Tingley, 2010 for mediation analysis; Imbens & Rubin, 2015, p. 517). 
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4. Participants in the control condition cannot access the treatment (referred to as 
one-sided nonadherence), such that 𝐷𝑖(0) is assumed to equal zero for all 
participants. 
5. The functional form of the dose-response curve is correctly specified.  Dunn and 
Bentall (2007) and Maracy and Dunn (2011) outlined instrumental variable 
methods when assuming either a linear or quadratic dose-response curve.  Only a 
linear dose-response curve is considered here. 
6. When modeling a linear dose-response curve, one plausible instrument must exist.  
Modeling a quadratic dose-response curve requires at least two instruments.  
More generally, at least as many instruments as endogenous regressors are 
needed. 
7. Due to the exclusion restriction, the average treatment effect is zero for 
participants who receive a dose of zero. 
Under these assumptions, we can estimate a dose-response curve for participants with 
𝐷𝑖(1) > 0. 
 With a single binary instrument (e.g., treatment assignment), the average linear 
effect of receiving more of the treatment for participants with 𝐷𝑖(1) > 0 can be estimated 
as 
 
E[𝑌𝑖|𝑍𝑖 = 1] − E[𝑌𝑖|𝑍𝑖 = 0]
E[𝐷𝑖|𝑍𝑖 = 1] − E[𝐷𝑖|𝑍𝑖 = 0]
 (5) 
where 𝑌𝑖 is the outcome, 𝐷𝑖 is treatment received (dose), and 𝑍𝑖 is treatment assignment 
(1 = treatment, 0 = control).  Under one-sided nonadherence (Assumption 4), 
E[𝐷𝑖|𝑍𝑖 = 0] = 0 such that the denominator equals the average dose in the treatment 
 20  
condition (i.e., E[𝐷𝑖|𝑍𝑖 = 1]).  Equation 5 is known as the Wald estimator (Wald, 1940); 
it is the ratio of the average effect of treatment assignment on the outcome (i.e., the 
intent-to-treat effect defined in Equation 3) to the average effect of treatment assignment 
on treatment received.  Because we assume that 𝑍𝑖 is only associated with 𝑌𝑖 through 𝐷𝑖 
(Conditions 2 and 3), dividing the variation in 𝑌𝑖 that is generated by variation in 𝑍𝑖 (the 
numerator of Equation 5) by the variation in 𝐷𝑖 that is generated by variation in 𝑍𝑖 (the 
denominator of Equation 5) consistently estimates the causal effect of 𝐷𝑖 on 𝑌𝑖 (Morgan 
& Winship, 2015).  Condition 1 ensures that the denominator of Equation 5 is nonzero. 
 The Wald estimator is restricted to a single binary instrument and no covariates.  
A more general procedure outlined by Dunn and Bentall (2007) and Maracy and Dunn 
(2011) estimates dose-response effects using two-stage least squares (TSLS).
6
  For a 
linear dose-response curve, TSLS estimation involves the following steps. 
1. Stage 1: Using data from all participants (in both the treatment and control 
conditions), treatment received 𝐷𝑖 (e.g., number of sessions attended where 
𝐷𝑖 = 0 for all participants in the control condition) is regressed on treatment 
assignment and the baseline covariates.  The resulting model is used to calculate 
predicted scores ?̂?𝑖 for all participants. 
2. Stage 2: The outcome is regressed on ?̂?𝑖 and the baseline covariates.  This model 
does not include treatment assignment due to the exclusion restriction (i.e., 
because we assume that treatment assignment only affects the outcome via 
treatment actually received).  The regression coefficient for ?̂?𝑖 represents the 
                                                 
6
 Interested readers should refer to Fischer-Lapp and Goetghebeur (1999), Dunn and Bentall (2007), and 
Maracy and Dunn (2011) for a procedure based on structural mean modeling with G-estimation. 
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average linear effect of receiving more of the treatment for participants with 
𝐷𝑖(1) > 0. 
Unlike 𝐷𝑖, ?̂?𝑖 is not endogenous because it is a linear function of treatment assignment 
and the baseline covariates, which we assume are exogenous (DeMaris, 2014).  The 
inclusion of baseline covariates is not required but increases efficiency when the baseline 
covariates are strongly associated with 𝐷𝑖 (Dunn & Bentall, 2007). 
 When sequentially estimating the first and second stage equations, the residuals 
from the second stage equation are calculated using ?̂?𝑖, which does not account for 
uncertainty in the predicted scores.  Instead, the observed scores 𝐷𝑖 should be used to 
calculate the residuals in the second stage equation (Hanushek & Jackson, 1977, pp. 267-
269; Angrist & Pischke, 2009, p. 140; Wooldridge, 2010, pp. 101-102), which is 
automated by specialized software routines (e.g., the SYSLIN procedure in SAS; Angrist 
& Pischke, 2009, p. 122).  This estimate of the residual variance is then used to calculate 
the standard errors of the regression coefficients in the second stage equation.
7
 
 The instrumental variable method can be implemented using other estimators, 
including limited information maximum likelihood, Bayesian, generalized method of 
methods, and structural mean modeling (see Burgess, Small, & Thompson, 2015 for a 
review).  With a single instrument, these estimators (excluding Bayesian) provide the 
same causal estimate as the TSLS estimator described in this section (Burgess et al., 
2015).  In this dissertation, I implement the instrumental variable method using TSLS 
                                                 
7
 Dunn and Bentall (2007), Maracy and Dunn (2011), and Ginestet et al. (2017) assumed homoscedasticity 
of the residuals in the first and second stage equations, which I also assume throughout this dissertation. 
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estimation.  TSLS estimation is available through the SYSLIN procedure in SAS as well 
as several other statistical software packages (e.g., R, Stata). 
 Weak instruments. Instruments that are only weakly associated with receipt of 
treatment present several issues.  First, the instrumental variable method is biased in 
finite samples, particularly with weak instruments (Bound, Jaeger, & Baker, 1995; 
Morgan & Winship, 2015).  To understand why, consider the Wald estimator in 
Equation 5.  Suppose that the average effect of treatment assignment on treatment 
received is zero in the population.  In a finite sample, the estimated average effect of 
treatment assignment on treatment received and thus the denominator of Equation 5 will 
likely be nonzero but small (Hernán & Robins, in press).  A small denominator will 
inflate the estimate of the dose-response effect.  Second, using too many weak 
instruments (i.e., specifying too many overidentifying restrictions) yields biased 
parameter estimates with confidence intervals that are too narrow (Bound et al., 1995; 
Staiger & Stock, 1997; Angrist & Pischke, 2009, pp. 205-209).  With fewer 
overidentifying restrictions, weak instruments yield parameter estimates with 
(appropriately) wide confidence intervals (Angrist & Pischke, 2009, p. 209).  Finally, 
violations of the exclusion restriction are most severe with weak instruments.  Violating 
the exclusion restriction biases the numerator of Equation 5 because the variation in 𝑌𝑖 
that is generated by variation in 𝑍𝑖 cannot be solely attributed to the association of 𝑍𝑖 
with 𝑌𝑖 through 𝐷𝑖; a small denominator (i.e., a weak instrument) amplifies this bias.
8
  
                                                 
8
 Stolzenberg and Relles (1990) and Virdin (1993) conducted simulations to evaluate the sensitivity of 
Heckman’s selection model to assumption violations, including violations of the exclusion restriction.  
Heckman (1976, 1979) proposed the selection model to correct for bias resulting from sample selection.  
Briefly, Heckman’s selection model combines the model of interest with a model for selection (e.g., 
adherence) and correlates their residuals.  These two models can share predictors, but the model for 
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The exclusion restriction is often considered the most problematic assumption of the 
instrumental variable method.  Thus, violations of the exclusion restriction are 
investigated in the simulations that follow. 
Previous Research 
 Confounder adjustment and instrumental variable methods have been extensively 
discussed and evaluated in the literature (e.g., Hanushek & Jackson, 1977; Cohen, Cohen, 
West, & Aiken, 2003; Angrist & Pischke, 2009; Wooldridge, 2010; Morgan & Winship, 
2015; Hernán & Robins, in press).  However, most existing research on the instrumental 
variable method, particularly in the context of nonadherence, focuses on binary 
endogenous regressors (e.g., Bound et al., 1995; Angrist, Imbens, & Rubin, 1996; Staiger 
& Stock, 1997; Jo, 2002; DeMaris, 2014).  Factors commonly manipulated in simulations 
comparing confounder adjustment and instrumental variable methods include sample 
size, strength of the instrument(s), violations of the exclusion restriction, and strength of 
unobserved confounding.  As discussed earlier, these simulations suggest that the 
instrumental variable method performs poorly (high bias and low precision) with small 
sample sizes and with weak or invalid instruments.  When unobserved confounding is 
weak or absent, the confounder adjustment method (properly specified) outperforms the 
instrumental variable method (low to no bias and high precision). 
 Fischer-Lapp and Goetghebeur (1999), Dunn and Bentall (2007), Maracy and 
Dunn (2011), and Ginestet et al. (2017) conducted simulations investigating confounder 
adjustment and instrumental variable methods for dose-response effects.  In the first three 
                                                                                                                                                 
selection should contain at least one predictor not in the model of interest (referred to as an exclusion 
restriction). 
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of these papers, the endogenous regressor was defined as a linear combination of 
normally distributed variables and ranged from zero to one to represent the proportion of 
dose received.
9
  All four papers generated unobserved confounding, but the number of 
other factors manipulated was limited.  In addition to unobserved confounding (absent, 
moderate, strong), Ginestet et al. (2017) manipulated the sample size (N = 100, 300, 500) 
and strength of the instruments (weak, moderate, strong).  However, their objective was 
to compare their proposed semi-parametric Stein-like estimator to the OLS and TSLS 
estimators rather than to evaluate the performance of the OLS and TSLS estimators.  
None of the four papers investigated violations of the exclusion restriction or varied the 
adherence distribution. 
Purpose of Dissertation 
 I conducted Monte Carlo simulations to examine when linear dose-response 
effects can be accurately and precisely estimated in randomized experiments comparing a 
no-treatment control condition to a treatment condition with partial adherence.  Monte 
Carlo simulations help determine the finite sampling properties of estimators, unlike 
analytic derivations that establish the asymptotic properties of estimators.  The first 
simulation study evaluated the performance of the confounder adjustment and 
instrumental variable methods when their assumptions were met.  The second simulation 
study assessed the sensitivity of the confounder adjustment and instrumental variable 
methods to assumption violations.  In addition to the confounder adjustment and 
instrumental variable methods, the intent-to-treat method was applied in both simulation 
studies. 
                                                 
9
 Generated values less than zero or greater than one were set to zero and one, respectively. 
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Simulation Study 1 Method 
 In Study 1, I compared the confounder adjustment and instrumental variable 
methods when their assumptions were met.  Although the manipulated factors (sample 
size, adherence distribution in the treatment condition, magnitude of the dose-response 
effect) did not represent assumption violations, I hypothesized that some of the 
conditions outlined below would be more optimal than others.  In particular, I expected 
the confounder adjustment method to provide unbiased estimates of the dose-response 
effect under all of the conditions investigated in Study 1 and to provide the greatest 
power when the sample size was large and the dose-response effect was strong.  Because 
treatment assignment served as a strong and valid instrument across all conditions 
(described in more detail below), I expected the instrumental variable method to provide 
unbiased estimates of the dose-response effect except perhaps when the sample size was 
small (N = 200).  Finally, I expected the instrumental variable method to provide the 
greatest power when the sample size was large, dose-response effect was strong, and 
adherence distribution in the treatment condition was either uniform or left skewed. 
Manipulated Factors 
 I implemented a full factorial design with three factors: sample size (200, 500, 
2,000), adherence distribution in the treatment condition (uniform, right skewed, left 
skewed), and magnitude of the dose-response effect (zero, 𝜌𝑌𝐷 = .00; weak, 𝜌𝑌𝐷 = .10; 
moderate, 𝜌𝑌𝐷 = .30; strong, 𝜌𝑌𝐷 = .50).  The manipulated factors and their levels are 
summarized in the first block of Table 2.  Manipulating these factors produced 36 design 
cells.  Each design cell contained 1,000 replications, yielding a total of 36,000 samples to 
analyze. 
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 Sample size was manipulated because the instrumental variable method provides 
consistent, but not unbiased, parameter estimates (Hanushek & Jackson, 1977; Angrist & 
Krueger, 2001).  Although samples of 200 and 500 participants are common in 
psychological research, the instrumental variable method may require large samples (e.g., 
2,000; Dunn & Bentall, 2007; DeMaris, 2014).  The magnitude of the dose-response 
effect was manipulated to examine the Type I error rate and power.  A zero, weak, 
moderate, or strong dose-response effect was represented by 𝜌𝑌𝐷 = .00, .10, .30, or .50, 
respectively, based on Cohen’s (1988) effect size guidelines. 
 Finally, the adherence distribution in the treatment condition was manipulated to 
represent adherence patterns of theoretical or practical interest.  Most previous 
simulations investigating the performance of the instrumental variable method have 
assumed that adherence (or some other endogenous regressor) was binary and have 
manipulated the proportion of cases in the two levels (e.g., Chiburis, Das, & Lokshin, 
2011, 2012; DeMaris, 2014).  For example, DeMaris (2014) varied the proportion of 
cases in each level of the endogenous regressor (50 – 50 versus 15 – 85 split) and found 
that the uneven split worsened the performance (mean square error and power) of the 
instrumental variable method under some conditions.  In the present study, adherence in 
the treatment condition was generated as discrete with nine categories (range = 0, 1,…, 8) 
and with either a uniform, right skewed, or left skewed distribution (see Figure 1).  These 
nine categories might represent attending between zero and eight sessions of an 
intervention.  Under a uniform adherence distribution, each level of adherence consisted 
of 
1
9
 ≈ 11.1% of cases, in expectation.  Proportions of .17, .14, .13, .11, .10, .10, .09, .08, 
and .08 (for zero to eight sessions) were used to define the right skewed adherence 
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distribution, and proportions of .08, .08, .09, .10, .10, .11, .13, .14, and .17 (for zero to 
eight sessions) were used to define the left skewed adherence distribution.  With these 
proportions, the variance of the (right or left) skewed adherence distribution (6.6731) 
approximately equaled the variance of the uniform adherence distribution (6.6667, 
difference = 0.0064).  However, the means of the uniform, right skewed, and left skewed 
adherence distributions differed (4.0000, 3.3700, 4.6300).  A right skewed adherence 
distribution would occur when many participants never initiate or only minimally adhere 
to their assigned treatment (e.g., the effectiveness trial of the New Beginnings Program 
described earlier where 23.3% of parents never attended).  A left skewed adherence 
distribution would occur when most participants fully or almost fully adhere to their 
assigned treatment (e.g., the efficacy trial of the New Beginnings Program where mothers 
attended an average of 82.8% of the sessions; Wolchik et al., 2000). 
 Notice that the left skewed adherence distribution mirrored the right skewed 
adherence distribution.  However, the effect of treatment assignment on treatment 
received was stronger with a left skewed adherence distribution than with a right skewed 
adherence distribution.  Given previous research on instrumental variable methods, 
differences in performance across the right and left skewed adherence distributions may 
be due to differences in the magnitude of the effect of treatment assignment on treatment 
received but cannot be due to differences in data sparseness.  However, differences in 
performance across the uniform and (right or left) skewed adherence distributions may be 
due to differences in data sparseness or differences in the magnitude of the effect of 
treatment assignment on treatment received.  The expected correlation between treatment 
assignment and treatment received was .7385 with a uniform adherence distribution, 
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.6780 with a right skewed adherence distribution, and .7850 with a left skewed adherence 
distribution.  Because treatment assignment served as a strong instrument across all 
conditions, the undesirable properties of weak instruments outlined earlier did not apply. 
Data Generation and Fitted Models 
 All of the data were generated and analyzed in SAS 9.4.  Data generation 
proceeded according to the following steps. 
1. For all cases, I generated treatment assignment 𝑍𝑖 (1 = treatment, 0 = control) by 
randomly drawing from a Bernoulli distribution with probability of success .50. 
2. For cases in the control condition, I set 𝐷𝑖 = 0 and generated the outcome 𝑌𝑖 by 
randomly drawing from a standard normal distribution (mean = 0, variance = 1). 
3. For cases in the treatment condition, I generated adherence 𝐷𝑖 by randomly 
drawing from a standard normal distribution (mean = 0, variance = 1) and then 
creating nine categories (range = 0, 1,…, 8) based on thresholds of z = −1.2206, 
−0.7647, −0.4307, −0.1397, 0.1397, 0.4307, 0.7647, 1.2206 (for a uniform 
adherence distribution), z = −0.9542, −0.4959, −0.1510, 0.1257, 0.3853, 0.6745, 
0.9945, 1.4051 (for a right skewed adherence distribution), or z = −1.4051, 
−0.9945, −0.6745, −0.3853, −0.1257, 0.1510, 0.4959, 0.9542 (for a left skewed 
adherence distribution).  These thresholds correspond to the proportions listed in 
the previous section. 
4. For cases in the treatment condition, I generated the outcome 𝑌𝑖 according to the 
following equation: 
 𝑌𝑖 = 𝑏1𝐷𝑖 + 𝜀𝑖 (6) 
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 where 𝐷𝑖 is adherence.  I generated 𝜀𝑖 by randomly drawing from a normal 
 distribution (mean = 0, variance = 𝜎𝜀
2).  As described in Appendix B, the specified 
 values of the (unstandardized) regression coefficient and residual variance in 
 Equation 6 were 𝑏1 = 0.0000 and 𝜎𝜀
2 = 1.0000, 𝑏1 = 0.0387 and 𝜎𝜀
2 = 0.9900, 
 𝑏1 = 0.1162 and 𝜎𝜀
2 = 0.9100, or 𝑏1 = 0.1936 and 𝜎𝜀
2 = 0.7500 to achieve a 
 zero (𝜌𝑌𝐷 = .00), weak (𝜌𝑌𝐷 = .10), moderate (𝜌𝑌𝐷 = .30), or strong (𝜌𝑌𝐷 = .50) 
 dose-response effect.  Equation 6 did not include an intercept such that 
 E[𝑌𝑖|𝑍𝑖 = 1,𝐷𝑖 = 0] = E[𝑌𝑖|𝑍𝑖 = 0] = 0.  That is, the expected value of 𝑌𝑖 for 
 cases in the treatment condition with 𝐷𝑖 = 0 equaled the expected value of 𝑌𝑖 for 
 cases in the control condition, which was zero. 
 For each of the 36,000 samples, I applied the intent-to-treat and confounder 
adjustment methods using the REG procedure in SAS and the instrumental variable 
method using the SYSLIN procedure in SAS (see Appendix C for example code).  When 
performing TSLS estimation via the SYSLIN procedure, the second stage equation did 
not include an intercept (NOINT option) due to the exclusion restriction. 
Evaluation Criteria 
 The results were evaluated based on bias, standardized bias, confidence interval 
coverage, confidence interval width, power, and Type I error rate.  The parameters of 
interest were the intent-to-treat effect and the dose-response effect.  Bias refers to the 
difference between the average parameter estimate across the 1,000 replications within a 
given design cell and the corresponding population parameter.
10
  Standardized bias was 
                                                 
10
 To assess bias introduced by categorizing adherence, I generated a sample with 25,000,000 cases within 
each design cell and obtained parameter estimates from a correctly specified model.  Differences between 
these parameter estimates and the corresponding population parameters specified in SAS ranged from 
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calculated by dividing bias by the standard deviation of the parameter estimate across the 
1,000 replications within a given design cell (i.e., the empirical standard error).  Collins, 
Schafer, and Kam (2001) suggested that standardized bias noticeably and adversely 
affects Type I and Type II error rates, efficiency, and confidence interval coverage when 
standardized bias exceeds |0.40| or |0.50|.  These standardized bias values indicate that the 
parameter estimate on average fell more than 0.40 or 0.50 standard errors above or below 
the population parameter.  I deemed standardized bias values greater than |0.40| 
problematic.  The confidence interval coverage rate refers to the proportion of 
replications where the 95% confidence interval contained the population parameter.  
Following Collins et al. (2001), I deemed coverage rates below 90% problematic.  The 
confidence interval width measures precision and refers to the difference between the 
upper and lower bounds.  Power and Type I error rate were evaluated based on the 
proportion of replications where the 95% confidence interval did not contain zero.  This 
proportion should equal the nominal significance level 𝛼 = .05 when the population 
parameter was zero, though Type I error rates within [.0365, .0635] were deemed 
acceptable.  When the population parameter was zero and the null hypothesis was 
rejected, I also examined the proportion of replications where zero was above (below) the 
confidence interval.  This proportion should equal 
𝛼
2
 = .025, though right (left) tail 
rejection rates within [.0153, .0347] were deemed acceptable.
11
 
                                                                                                                                                 
−0.00018 to −0.00007 for the intent-to-treat method, 0.00003 to 0.00006 for the confounder adjustment 
method, and −0.00003 to −0.00002 for the instrumental variable method.  The population parameters 
specified in SAS were used in the calculations described in this section. 
11
 The 95% confidence intervals for the Type I error rate and right (left) tail rejection rate were calculated 
as 𝑝 ± 1.96√𝑝(1 − 𝑝) 𝑛⁄  where 𝑝 is the proportion of interest (.05 or .025) and 𝑛 is the number of 
replications.  With 1,000 replications, the 95% confidence intervals for the Type I error rate and right (left) 
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Simulation Study 1 Results 
 Table 3 reports bias and confidence interval coverage for all 36 conditions 
investigated in Study 1.  Table 4 reports confidence interval width, Type I error rate, and 
power. 
Intent-to-Treat Effect 
 As shown in Table 3, estimates of the intent-to-treat effect were unbiased on 
average across all conditions (bias range = −0.0026 to 0.0005, standardized bias 
range = −0.0258 to 0.0056).  Coverage rates ranged from .9400 to .9570.  For the nine 
conditions where the population parameter was zero, Type I error rates ranged from 
.0440 to .0570, right tail rejection rates ranged from .0220 to .0310, and left tail rejection 
rates ranged from .0210 to .0260.  For the 27 conditions where the population parameter 
was nonzero, power ranged from .1470 to 1.0000 depending on the sample size and the 
magnitude of the dose-response effect.  As shown in Table 4, power increased as the 
sample size and dose-response effect increased.  Conditions with a left skewed adherence 
distribution provided the greatest power, followed by conditions with a uniform 
adherence distribution and then conditions with a right skewed adherence distribution.  
Power varied by adherence distribution because the means of the left skewed, uniform, 
and right skewed adherence distributions differed (4.6300, 4.0000, 3.3700), which 
affected the magnitude of the intent-to-treat effect.  However, as shown in Table 4, the 
confidence interval width did not vary by adherence distribution (range = 0.5562 to 
                                                                                                                                                 
tail rejection rate were . 05 ± 1.96√. 05(1 − .05) 1,000⁄ = [.0365, .0635] and 
. 025 ± 1.96√. 025(1 − .025) 1,000⁄ = [.0153, .0347], respectively. 
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0.5568, 0.3513 to 0.3515, and 0.1754 to 0.1755 for conditions with N = 200, 500, or 
2,000, respectively). 
Dose-Response Effect 
 As shown in Table 3, estimates of the dose-response effect were unbiased on 
average across all conditions (confounder adjustment: bias range = −0.0015 to −0.0002, 
standardized bias range = −0.0375 to −0.0173; instrumental variable: bias 
range = −0.0003 to 0.0002, standardized bias range = −0.0331 to 0.0131).  Coverage rates 
ranged from .9440 to .9560 for the confounder adjustment method and from .9470 to 
.9690 for the instrumental variable method. 
 For the nine conditions where the population parameter was zero, Type I error 
rates, right tail rejection rates, and left tail rejection rates ranged from .0440 to .0560, 
.0230 to .0350, and .0200 to .0220, respectively, for the confounder adjustment method 
and from .0470 to .0530, .0210 to .0240, and .0240 to .0290, respectively, for the 
instrumental variable method.  For the 27 conditions where the population parameter was 
nonzero, power ranged from .1670 to 1.0000 for the confounder adjustment method and 
from .2590 to 1.0000 for the instrumental variable method.  As shown in Table 4, power 
increased as the sample size and dose-response effect increased.  The adherence 
distribution did not affect power for the confounder adjustment method.  However, for 
the instrumental variable method, conditions with a left skewed adherence distribution 
provided the greatest power, followed by conditions with a uniform adherence 
distribution and then conditions with a right skewed adherence distribution.  Differences 
in the strength of the instrument may explain this pattern of results.  Recall that the 
expected correlation between treatment assignment and treatment received was .7850 
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with a left skewed adherence distribution, .7385 with a uniform adherence distribution, 
and .6780 with a right skewed adherence distribution.  However, as discussed earlier, 
differences in power across the uniform and (right or left) skewed adherence may also be 
due to differences in data sparseness.  Finally, the instrumental variable method 
consistently provided greater power than the confounder adjustment method (until power 
approached its upper asymptote of 1.0000), and the confounder adjustment method 
provided confidence intervals that were between 1.2079 and 1.7998 times wider than 
those from the instrumental variable method (confidence interval width range = 0.0416 to 
0.1531 and 0.0251 to 0.1171, respectively).  This is because the confounder adjustment 
method used data from only those cases in the treatment condition, whereas the 
instrumental variable method used data from cases in both the treatment and control 
conditions. 
Simulation Study 2 Method 
 In Study 2, I compared the confounder adjustment and instrumental variable 
methods when their assumptions were violated.  Specifically, I investigated sensitivity to 
unobserved confounding (an assumption of the confounder adjustment method but not 
the instrumental variable method) and to violations of the exclusion restriction (an 
assumption of the instrumental variable method but not the confounder adjustment 
method).  I hypothesized that the confounder adjustment and instrumental variable 
methods would perform poorly (high bias) when their assumptions were violated.  
However, the severity of these assumption violations was unknown. 
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Manipulated Factors 
 I implemented a full factorial design with three factors: magnitude of the dose-
response effect (zero, 𝜌𝑌𝐷 = .00; weak, 𝜌𝑌𝐷 = .10; moderate, 𝜌𝑌𝐷 = .30; strong, 
𝜌𝑌𝐷 = .50), unobserved confounding (absent, 𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .00; weak, 𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .10; 
moderate, 𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .30; strong, 𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .50), and magnitude of the direct effect 
of treatment assignment on the outcome (zero, 𝛿 = 0.00; weak, 𝛿 = 0.20; moderate, 
𝛿 = 0.50).  The magnitude of the dose-response effect was manipulated to examine the 
Type I error rate and power (see Study 1).  The effect of the unobserved confounder on 
adherence in the treatment condition and the effect of the unobserved confounder on the 
outcome were equal.  No, weak, moderate, or strong unobserved confounding was 
represented by 𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .00, .10, .30, or .50 respectively, based on Cohen’s (1988) 
effect size guidelines for product-moment correlations.  The magnitude of the direct 
effect of treatment assignment on the outcome (exclusion restriction violation) was 
manipulated by adding a constant difference between the treatment and control 
conditions on the outcome.  No, weak, or moderate exclusion restriction violations were 
represented by 𝛿 = 0.00, 0.20, or 0.50, respectively, based on Cohen’s (1988) effect size 
guidelines for standardized mean differences.  The sample size was set to 2,000 across all 
conditions.  The manipulated factors and their levels are summarized in the second block 
of Table 2.  Manipulating these factors produced 48 design cells.  Each design cell 
contained 1,000 replications, yielding a total of 48,000 samples to analyze. 
Data Generation and Fitted Models 
 All of the data were generated and analyzed in SAS 9.4.  Data generation 
proceeded according to the following steps. 
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1. For all cases, I generated treatment assignment 𝑍𝑖 (1 = treatment, 0 = control) by 
randomly drawing from a Bernoulli distribution with probability of success .50. 
2. For cases in the control condition, I set 𝐷𝑖 = 0 and generated the unobserved 
confounder 𝑈𝑖 and outcome 𝑌𝑖 by randomly drawing from a bivariate normal 
distribution with mean vector [
0
0
] and covariance matrix [
1 𝜌𝑌𝑈
𝜌𝑌𝑈 1
].  𝜌𝑌𝑈 
equaled .00, .10, .30, or .50 for conditions with no, weak, moderate, or strong 
unobserved confounding, respectively. 
3. For cases in the treatment condition, I generated the unobserved confounder 𝑈𝑖 
and adherence 𝐷𝑖 by randomly drawing from a bivariate normal distribution with 
mean vector [
0
0
] and covariance matrix [
1 𝜌𝐷𝑈
𝜌𝐷𝑈 1
] where 𝜌𝐷𝑈 equaled .00, .10, 
.30, or .50.  I then created nine categories for 𝐷𝑖 (range = 0, 1,…, 8) based on 
thresholds of z = −1.2206, −0.7647, −0.4307, −0.1397, 0.1397, 0.4307, 0.7647, 
1.2206 (for a uniform adherence distribution with 
1
9
 ≈ 11.1% of cases in each level 
of adherence).  Only the uniform adherence distribution was considered in 
Study 2. 
4. For cases in the treatment condition, I generated the outcome 𝑌𝑖 according to the 
following equation: 
 𝑌𝑖 = 𝑏0 + 𝑏1𝐷𝑖 + 𝑏2𝑈𝑖 + 𝜀𝑖 (7) 
 where 𝐷𝑖 is adherence and 𝑈𝑖 is the unobserved confounder.  I generated 𝜀𝑖 by 
 randomly drawing from a normal distribution (mean = 0, variance = 𝜎𝜀
2).  
 Appendix B provides the specified values of the (unstandardized) regression 
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 coefficients and residual variance to manipulate the dose-response effect, strength 
 of unobserved confounding, and violation of the exclusion restriction. 
Conditions with no unobserved confounding and no violation of the exclusion restriction 
overlapped with conditions from Study 1 with a uniform adherence distribution.
12
 
 For each of the 48,000 samples, I applied the intent-to-treat and confounder 
adjustment methods using the REG procedure in SAS and the instrumental variable 
method using the SYSLIN procedure in SAS (see Appendix C for example code).  When 
performing TSLS estimation via the SYSLIN procedure, the second stage equation did 
not include an intercept (NOINT option) due to the exclusion restriction.  However, the 
exclusion restriction was violated under some of the conditions investigated in Study 2.  
Similarly, 𝑈𝑖 was omitted when applying the confounder adjustment method, which was 
an assumption violation under some of the conditions investigated in Study 2. 
Evaluation Criteria 
 As in Study 1, the results were evaluated based on bias, standardized bias, 
confidence interval coverage, confidence interval width, power, and Type I error rate.
13
  
When the population parameter was zero and the null hypothesis was rejected, I also 
examined the proportion of replications where zero was above (below) the confidence 
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 New data were generated and analyzed for Study 2 conditions that overlapped with Study 1 conditions.  
The results were consistent across Studies 1 and 2 for these conditions. 
13
 To assess bias introduced by categorizing adherence, I generated a sample with 25,000,000 cases within 
each design cell and obtained parameter estimates from a correctly specified model.  Differences between 
these parameter estimates and the corresponding population parameters specified in SAS ranged from 
−0.00030 to −0.00023 for the intent-to-treat method, 0.00005 to 0.00009 for the confounder adjustment 
method, and 0.00000 to 0.00002 for the instrumental variable method.  The population parameters specified 
in SAS were used in the calculations described in this section.  Relative to the analysis models in Appendix 
C, the correctly specified models also included the unobserved confounder.  For design cells where the 
exclusion restriction was violated, parameter estimates from the corresponding design cells with no 
exclusion restriction violation were compared to the population parameters specified in SAS. 
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interval.  The parameters of interest were the intent-to-treat effect and the dose-response 
effect. 
Simulation Study 2 Results 
 Figure 2 plots bias for all 48 conditions investigated in Study 2.  Table 5 reports 
bias and confidence interval coverage by unobserved confounding and exclusion 
restriction violation; bias and confidence interval coverage were averaged across strength 
of the dose-response effect (zero, weak, moderate, strong) in Table 5. 
Intent-to-Treat Effect 
 As shown in Figure 2, estimates of the intent-to-treat effect were unbiased on 
average across all conditions (bias range = −0.0009 to −0.0006, standardized bias 
range = −0.0215 to −0.0141).  Coverage rates ranged from .9540 to .9620.  For the 
condition where the population parameter was zero, the Type I error rate, right tail 
rejection rate, and left tail rejection rate fell within the acceptable ranges.  For the 47 
conditions where the population parameter was nonzero, power increased as the 
magnitude of the population parameter increased, whereas the confidence interval width 
remained fairly constant across conditions (range = 0.1752 to 0.1757). 
Dose-Response Effect 
 Confounder adjustment method. For conditions with no unobserved 
confounding (𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .00), estimates of the dose-response effect were unbiased on 
average (bias range = −0.0004 to −0.0003, standardized bias = −0.0327 for all conditions) 
and coverage rates equaled .9570 (for all conditions).  For conditions with weak 
unobserved confounding (𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .10), estimates of the dose-response effect were 
more biased on average (bias range = 0.0016 to 0.0034), though standardized bias and 
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coverage rates still fell within the acceptable ranges (standardized bias range = 0.1544 to 
0.2884, coverage rates range = .9530 to .9600).  However, estimates of the dose-response 
effect were biased on average and coverage rates were low for conditions with moderate 
unobserved confounding (𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .30; bias range = 0.0182 to 0.0367, standardized 
bias range = 1.7477 to 3.0415, coverage rates range = .1580 to .5840) and conditions with 
strong unobserved confounding (𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .50; bias range = 0.0620 to 0.1243, 
standardized bias range = 5.8863 to 10.1253, coverage rate = .0000 for all conditions).
14
  
As shown in Figure 2, bias was unaffected by violations of the exclusion restriction (an 
assumption of the instrumental variable method but not the confounder adjustment 
method). 
 For the three conditions where the population parameter was zero, the Type I 
error rate, right tail rejection rate, and left tail rejection rate fell within the acceptable 
ranges.  For the 45 conditions where the population parameter was nonzero, power 
increased as the magnitude of the population parameter increased, whereas the 
confidence interval width remained fairly constant across conditions (range = 0.0417 to 
0.0483). 
 Instrumental variable method. For conditions where the exclusion restriction 
was met (𝛿 = 0.00), estimates of the dose-response effect were unbiased on average (bias 
range = −0.0001 to 0.0000, standardized bias range = −0.0098 to 0.0012) and coverage 
rates ranged from .9450 to .9680.  However, estimates of the dose-response effect were 
                                                 
14
 Standardized bias increases as sample size increases because parameters are more precisely estimated.  
Thus, I investigated standardized bias when N = 200.  Although standardized bias was lower in magnitude 
when the sample size was 200 instead of 2,000, the conclusions remained the same.  Standardized bias was 
less than |0.40| for conditions with no or weak unobserved confounding but greater than |0.40| for 
conditions with moderate or strong unobserved confounding. 
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extremely biased on average and coverage rates dropped to zero for conditions with a 
weak exclusion restriction violation (𝛿 = 0.20; bias range = .04995 to .05004, 
standardized bias range = 6.1170 to 7.3416) and conditions with a moderate exclusion 
restriction violation (𝛿 = 0.50; bias range = 0.1250 to 0.1251, standardized bias 
range = 15.1761 to 18.0134).
15,16
  As shown in Figure 2, bias was unaffected by 
unobserved confounding (an assumption of the confounder adjustment method but not 
the instrumental variable method). 
 For the condition where the population parameter was zero and the exclusion 
restriction was met, the Type I error rate, right tail rejection rate, and left tail rejection 
rate fell within the acceptable ranges.  However, for the two conditions where the 
population parameter was zero and the exclusion restriction was violated, the Type I error 
rate equaled 1.0000 and zero always fell below the confidence interval.  That is, the 
positive direct effect of treatment assignment on the outcome was mistakenly considered 
a positive dose-response effect.  For the 45 conditions where the population parameter 
was nonzero, power increased as the magnitude of the population parameter increased, 
whereas the confidence interval width remained fairly constant across conditions 
(range = 0.0290 to 0.0319).  As in Study 1, the instrumental variable method provided 
                                                 
15
 When the sample size was 200 instead of 2,000, standardized bias was less than |0.40| for conditions 
where the exclusion restriction was met but greater than |0.40| for conditions where the exclusion restriction 
was violated. 
16
 Even under less severe violations of the exclusion restriction (represented by standardized mean 
differences of 𝛿 = 0.05 and 0.10), estimates of the dose-response effect were biased on average and 
coverage rates were low (bias range = 0.0124 to 0.0125, standardized bias range = 1.4875 to 1.8550, 
coverage rates range = .6230 to .6600 for 𝛿 = 0.05; bias range = 0.0249 to 0.0250, standardized bias 
range = 3.0102 to 3.6984, coverage rates range = .0590 to .1440 for 𝛿 = 0.10). 
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narrower confidence intervals than did the confounder adjustment method (confidence 
interval width range = 0.0290 to 0.0319 and 0.0417 to 0.0483, respectively). 
Discussion 
 In randomized experiments, nonadherence occurs when participants’ received 
treatment differs from their assigned treatment.  In the presence of nonadherence, 
reporting intent-to-treat effects is widely recommended because intent-to-treat effects 
maintain the integrity of randomization (Sagarin et al., 2014; Gottfredson et al., 2015).  
However, intent-to-treat effects support causal inferences about the average effects of 
treatment assignment, not treatment received.  Dose-response effects can supplement 
intent-to-treat effects when participants are offered the full dose but many only receive a 
partial dose due to nonadherence.  Using these data, we can estimate the magnitude of the 
treatment effect at different levels of adherence, which serve as a proxy for different 
levels of treatment.  In this dissertation, I conducted Monte Carlo simulations to examine 
when linear dose-response effects can be accurately and precisely estimated in 
randomized experiments comparing a no-treatment control condition to a treatment 
condition with partial adherence.  Specifically, I evaluated the performance of 
confounder adjustment and instrumental variable methods when their assumptions were 
met (Study 1) and when their assumptions were violated (Study 2). 
 In Study 1, the confounder adjustment and instrumental variable methods 
provided unbiased estimates of the dose-response effect and acceptable coverage rates 
across all conditions (sample size of 200, 500, or 2,000; uniform, right skewed, or left 
skewed adherence distribution; zero, weak, moderate, or strong dose-response effect).  
These results were mostly consistent with my hypotheses.  However, I expected the 
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instrumental variable method to produce some bias when the sample size was small 
(N = 200) because the instrumental variable method provides consistent, but not 
unbiased, parameter estimates (Hanushek & Jackson, 1977; Angrist & Krueger, 2001).  
Nevertheless, this result from Study 1 was consistent with simulation results presented by 
Maracy and Dunn (2011) where the instrumental variable method provided unbiased 
estimates of the dose-response effect under a sample size of 200.  This lack of bias was 
likely due to treatment assignment serving as a very strong instrument (𝜌𝐷𝑍 = .7385, 
.6780, or .7850 with a uniform, right skewed, or left skewed adherence distribution).  By 
using data from cases in both the treatment and control conditions, the instrumental 
variable method consistently provided narrower confidence intervals and greater power 
(until power approached its upper asymptote of 1.0000) than the confounder adjustment 
method.  This power difference would be reversed if the confounder adjustment and 
instrumental variable methods were based on the same effective sample size (Ginestet et 
al., 2017).  Overall, the results from Study 1 suggested that when their assumptions are 
met, the confounder adjustment and instrumental variable methods can provide accurate 
and precise estimates of dose-response effects in randomized experiments typically 
conducted in psychological research (e.g., N = 200 participants, common adherence 
distributions). 
 In Study 2, the confounder adjustment method provided unbiased or minimally 
biased estimates of the dose-response effect under no or weak unobserved confounding 
(𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .00 or .10) but provided biased estimates of the dose-response effect under 
moderate or strong unobserved confounding (𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .30 or .50).  Bias was 
unaffected by violations of the exclusion restriction (an assumption of the instrumental 
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variable method but not the confounder adjustment method).  The instrumental variable 
method provided unbiased estimates of the dose-response effect when the exclusion 
restriction was met (𝛿 = 0.00) but provided extremely biased estimates of the dose-
response effect when the exclusion restriction was violated (𝛿 = 0.20 or 0.50).  Bias was 
unaffected by unobserved confounding (an assumption of the confounder adjustment 
method but not the instrumental variable method).  These results were consistent with my 
hypotheses, though the severity of the exclusion restriction violations was unexpected.  In 
a post hoc expansion of Study 2, the instrumental variable method provided biased 
estimates of the dose-response effect even under less severe exclusion restriction 
violations (𝛿 = 0.05 or 0.10).  When the exclusion restriction was violated, the magnitude 
of the dose-response effect was overestimated because the direct effect of treatment 
assignment on the outcome and the dose-response effect had the same sign (i.e., were 
both positive) in Study 2.  The magnitude of the dose-response effect would have been 
underestimated if the direct effect of treatment assignment on the outcome and the dose-
response effect had opposite signs.  In practice, researchers should use theory to consider 
the likely direction of bias and its implications for causal inferences. 
Limitations and Future Research 
 Although conditions for the simulation studies were chosen to represent published 
research, the generalizability of all simulation studies is limited.  First, in Study 1, three 
adherence distributions were investigated—uniform, right skewed, and left skewed.  
Another common adherence distribution is U-shaped with heavy right and left tails.  This 
adherence pattern occurs when many participants never initiate their assigned treatment, 
but those who initiate their assigned treatment fully or almost fully adhere to the 
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treatment regimen.  For example, consider the JOBS II intervention for preventing mental 
health problems and promoting high quality reemployment among unemployed workers 
(Vinokur, Price, & Schul, 1995).  Of the 1,249 unemployed workers randomly assigned 
to the JOBS II intervention, 578 (46.3%) never attended a session whereas 567 (45.4%) 
attended at least four of the five sessions.  Dichotomization might be defensible for a U-
shaped adherence distribution with extremely heavy right and left tails, a topic for future 
research. 
 Second, in Studies 1 and 2, cases were evenly split between the treatment and 
control conditions (as in Dunn & Bentall, 2007; Maracy & Dunn, 2011; Ginestet et al., 
2017).  Although an even split provides the greatest power to detect the intent-to-treat 
effect, uneven splits could be investigated to assess power to detect the dose-response 
effect (e.g., one-third of cases in the control condition and two-thirds of cases in the 
treatment condition).  For the confounder adjustment method, power will increase as the 
proportion of cases in the treatment condition increases because the confounder 
adjustment method uses data from only those cases in the treatment condition.  It is less 
clear how the proportion of cases in the treatment condition affects power for the 
instrumental variable method.  Assigning a higher proportion of cases to the treatment 
condition provides more information about the expected value of 𝑌𝑖 when 𝐷𝑖 > 0 and the 
expected change in 𝑌𝑖 from a one-point increase in treatment received (e.g., from 
attending one more session).  At the same time, cases in the treatment condition that 
received a dose of zero and cases in the control condition each provide information about 
the expected value of 𝑌𝑖 when 𝐷𝑖 = 0 due to the exclusion restriction.  In a post hoc 
expansion of Study 1, assigning two-thirds rather than half of cases to the treatment 
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condition provided greater power to detect the dose-response effect (until power 
approached its upper asymptote of 1.0000) across all conditions.  However, the optimal 
split on treatment assignment may depend on the adherence distribution as well as other 
factors not considered in Study 1. 
 Third, the exclusion restriction violations considered in Study 2 may have been 
too severe or implausible, though less severe exclusion restriction violations considered 
in a post hoc expansion of Study 2 still produced substantial bias.  In Study 2, the 
exclusion restriction violations could be specified as an average difference between the 
treatment and control conditions on the outcome.  Creating an average difference rather 
than a constant difference between the treatment and control conditions on the outcome is 
more representative of empirical data. 
 Fourth, only a linear dose-response curve was considered in this dissertation.  
Studies 1 and 2 should be expanded to include nonlinear dose-response curves.  Dunn 
and Bentall (2007) and Maracy and Dunn (2011) outlined instrumental variable methods 
when assuming either a linear or quadratic dose-response curve, though other functional 
forms may be of interest.  In future research, bias resulting from misspecifications of the 
functional form of the dose-response curve—an assumption violation for both the 
confounder adjustment and instrumental variable methods—could be investigated. 
 Finally, in Studies 1 and 2, the expected treatment benefit for participants who 
attended all eight sessions could be computed.  The standard error of this predicted score 
can be calculated algebraically for OLS estimation (Cohen et al., 2003, p. 45) or via 
bootstrapping for both OLS and TSLS estimation.  The expected treatment benefit under 
other levels of adherence may also be of interest (e.g., attendance at four out of eight 
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sessions).  The accuracy and precision with which these predicted scores can be estimated 
may depend on the adherence distribution.  For example, the expected treatment benefit 
for participants who attended all eight sessions may be more accurately and precisely 
estimated under a left skewed adherence distribution than under a right skewed adherence 
distribution. 
Practical Recommendations 
 In practice, the confounder adjustment method’s no-unobserved-confounding 
assumption and the instrumental variable method’s exclusion restriction are strong and 
untestable assumptions (see Morgan & Winship, 2015, pp. 301-302).
17
  For the 
confounder adjustment method, collecting baseline covariates that theoretically relate to 
both adherence and the outcome (e.g., motivation) can reduce bias and increase power.  
Researchers should use theory to consider possible unobserved confounders and their 
relations to observed confounders.  Researchers should also assess the sensitivity of the 
results to unobserved confounding.  For example, Mauro (1990) proposed a sensitivity 
analysis based on the correlation between the unobserved confounder and focal predictor 
(treatment received) 𝜌𝐷𝑈 and the correlation between the unobserved confounder and 
outcome 𝜌𝑌𝑈.  Researchers can assess the impact of several plausible values of 𝜌𝐷𝑈 and 
𝜌𝑌𝑈 on the estimated dose-response effect.  The robustness of the estimated dose-
response effect to unobserved confounding has important implications for the 
interpretability and utility of the results. 
                                                 
17
 Researchers may mistakenly believe that the exclusion restriction implies that 𝑍𝑖 and 𝑌𝑖 are conditionally 
independent given 𝐷𝑖  and thus that the exclusion restriction is testable.  Morgan and Winship (2015, 
pp. 301-302) clarified that if 𝑍𝑖 is an invalid instrument, then 𝑍𝑖 will be associated with 𝑌𝑖 conditional on 
𝐷𝑖 .  However, the converse is not true.  That is, 𝑍𝑖 may be associated with 𝑌𝑖 conditional on 𝐷𝑖  even if 𝑍𝑖 is 
a valid instrument. 
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 For the instrumental variable method, researchers should use theory to consider 
why a direct effect of treatment assignment on the outcome might exist.  Returning to the 
New Beginnings Program (Sandler et al., 2017), being randomized to the control 
condition may have led parents to engage in other behaviors that prevented child mental 
health problems and substance use (e.g., seeking out other services).  Alternatively, being 
randomized to the control condition may have led to feelings of demoralization that 
exacerbated child mental health problems and substance use.  Other considerations 
include the likely direction of bias and the strength of the instrument.  Outlining a 
sensitivity analysis for violations of the exclusion restriction is a topic for future research 
(but see Hong, 2015, p. 265).  Although the instrumental variable method allows for 
unobserved confounding, collecting baseline covariates that theoretically relate to 
adherence can increase power (Dunn & Bentall, 2007).  Finally, researchers should 
consider all other assumptions listed in Table 1 before applying the confounder 
adjustment and instrumental variable methods. 
Extension to Psychological Research 
 Because dose-response estimation was primarily developed within medical and 
pharmacological research, additional considerations are necessary to extend dose-
response estimation to psychological research.  As one example, dose may be more 
difficult to quantify in psychological research.  In the New Beginnings Program, the first 
five sessions targeted parent-child relationship quality, the next session addressed 
children’s exposure to interparental conflict, and the remaining four sessions covered 
discipline.  Attendance at the first two sessions or attendance at the sixth and eighth 
sessions each conceivably represent a dose of two sessions, yet we may expect different 
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outcomes for these two families.  Weighting sessions by their importance in targeting a 
specific outcome may be advisable when each session does not represent an equal dose.  
That is, the last four sessions of the New Beginnings Program may be weighted more 
heavily than the first six sessions when investigating improvements in discipline, but a 
different set of weights may be used when investigating improvements in parent-child 
communication.  Dose may also be difficult to quantify when adherence to multiple 
components of an intervention is of interest, particularly when these components are 
interdependent (see West & Aiken, 1997 for a discussion).  In the New Beginnings 
Program, attendance and completion of home practice were interdependent such that 
skipping a session would preclude a parent from being assigned and thus completing the 
home practice before the next session. 
 As another example, measuring adherence without error may be more difficult 
depending on how adherence is defined and where adherence occurs.  In the New 
Beginnings Program, adherence may be defined as attendance, engagement during the 
sessions, or practicing the targeted skills following each session.  Attendance can be 
easily measured with little to no error.  However, engagement during the sessions is more 
ambiguous, and practicing the targeted skills is not directly observed by the 
interventionist.  Although measurement error is also problematic in medical and 
pharmacological research, addressing this issue may differ in psychological research.  For 
example, adherence to a drug regimen may be monitored by electronic vial caps that 
record when the vial was opened, electronic records of prescription refills, or chemical 
markers.  However, other innovative methods for promoting and monitoring adherence 
may apply to psychological research (e.g., reminders sent via mobile apps).  With random 
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measurement error on adherence, the instrumental variable method provides consistent 
estimates of dose-response effects (Foster, 2003; Goetghebeur & Vansteelandt, 2005; 
Dunn & Bentall, 2007; Maracy & Dunn, 2011) whereas the confounder adjustment 
method provides attenuated estimates of dose-response effects (but see Fritz, Kenny, & 
MacKinnon, 2016 for the combined effect of measurement error and unobserved 
confounding). 
 When the assumptions of the confounder adjustment and instrumental variable 
methods are met, supplementing intent-to-treat effects with dose-response effects can 
enhance our understanding of the treatment’s efficacy and potentially improve the 
generalizability of the results.  The confounder adjustment and instrumental variable 
methods described and evaluated in this dissertation allow for more widespread reporting 
of dose-response effects in psychological research, which may ultimately lead to more 
informed treatment decisions. 
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Table 1 
Summary of Assumptions for Confounder Adjustment and Instrumental Variable Methods 
Confounder Adjustment Method  Instrumental Variable Method 
Consistency  Consistency 
Stable unit treatment value assumption  Stable unit treatment value assumption 
Positivity  Randomized treatment assignment 
Adherence level measured without error  One-sided nonadherence 
Conditional independence of adherence level  1+ strong instruments 
Overlap of covariate distributions  Exclusion restriction 
Correctly specified functional form  Correctly specified functional form 
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Table 2 
Studies 1 and 2 Manipulated Factors 
Study  Factor  Levels  Values 
1  Sample Size  3  200 500 2,000  
  
Adherence 
Distribution 
 3  Uniform Right Skewed Left Skewed  
  Dose-Response Effect  4  
Zero 
𝜌𝑌𝐷 = .00 
Weak 
𝜌𝑌𝐷 = .10 
Moderate 
𝜌𝑌𝐷 = .30 
Strong 
𝜌𝑌𝐷 = .50 
2  Dose-Response Effect  4  
Zero 
𝜌𝑌𝐷 = .00 
Weak 
𝜌𝑌𝐷 = .10 
Moderate 
𝜌𝑌𝐷 = .30 
Strong 
𝜌𝑌𝐷 = .50 
  
Unobserved 
Confounding 
 4  
Absent 
𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .00 
Weak 
𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .10 
Moderate 
𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .30 
Strong 
𝜌𝐷𝑈 = 𝜌𝑌𝑈 = .50 
  
Exclusion Restriction 
Violation 
 3  
Absent 
𝛿 = 0.00 
Weak 
𝛿 = 0.20 
Moderate 
𝛿 = 0.50 
 
Note. The dose-response effect (Studies 1 and 2) and unobserved confounding (Study 2) were varied based on the product-
moment correlation 𝜌, whereas violation of the exclusion restriction (Study 2) was varied based on Cohen’s 𝛿. 
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Table 3 
Study 1 Bias and Confidence Interval Coverage for Intent-to-Treat, Confounder Adjustment, and Instrumental Variable 
Methods 
Condition  Bias  Confidence Interval Coverage 
Dose-Response 
Effect 
Sample 
Size 
Adherence 
Distribution 
 
Intent-
to-Treat 
Confounder 
Adjustment 
Instrumental 
Variable 
 
Intent-
to-Treat 
Confounder 
Adjustment 
Instrumental 
Variable 
Zero 200 Uniform  −0.0026 −0.0013 0.0001  .9550 .9450 .9500 
  Right Skewed  −0.0026 −0.0014 0.0001  .9550 .9440 .9500 
  Left Skewed  −0.0026 −0.0015 0.0001  .9550 .9440 .9500 
 500 Uniform  −0.0003 −0.0007 0.0002  .9560 .9500 .9470 
  Right Skewed  −0.0003 −0.0008 0.0002  .9560 .9550 .9470 
  Left Skewed  −0.0003 −0.0008 0.0002  .9560 .9520 .9470 
 2,000 Uniform  −0.0012 −0.0002 −0.0003  .9430 .9530 .9530 
  Right Skewed  −0.0012 −0.0003 −0.0003  .9430 .9560 .9530 
  Left Skewed  −0.0012 −0.0003 −0.0002  .9430 .9500 .9530 
Weak 200 Uniform  −0.0022 −0.0013 0.0001  .9520 .9450 .9500 
  Right Skewed  −0.0021 −0.0013 0.0001  .9510 .9440 .9500 
  Left Skewed  −0.0023 −0.0015 0.0001  .9520 .9440 .9500 
 500 Uniform  −0.0002 −0.0007 0.0002  .9520 .9500 .9470 
  Right Skewed  −0.0001 −0.0008 0.0002  .9560 .9550 .9470 
  Left Skewed  −0.0002 −0.0007 0.0002  .9520 .9520 .9470 
 2,000 Uniform  −0.0011 −0.0002 −0.0003  .9410 .9530 .9540 
  Right Skewed  −0.0011 −0.0002 −0.0003  .9410 .9560 .9550 
  Left Skewed  −0.0012 −0.0003 −0.0002  .9410 .9500 .9540 
Moderate 200 Uniform  −0.0013 −0.0012 0.0001  .9480 .9450 .9530 
  Right Skewed  −0.0011 −0.0013 0.0001  .9490 .9440 .9530 
  Left Skewed  −0.0016 −0.0014 0.0001  .9480 .9440 .9520 
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 500 Uniform  0.0000 −0.0006 0.0002  .9520 .9500 .9540 
  Right Skewed  0.0002 −0.0008 0.0002  .9520 .9550 .9540 
  Left Skewed  −0.0001 −0.0007 0.0002  .9540 .9520 .9520 
 2,000 Uniform  −0.0011 −0.0002 −0.0003  .9400 .9530 .9600 
  Right Skewed  −0.0010 −0.0002 −0.0003  .9410 .9560 .9600 
  Left Skewed  −0.0012 −0.0003 −0.0002  .9410 .9500 .9600 
Strong 200 Uniform  −0.0004 −0.0011 0.0001  .9510 .9450 .9680 
  Right Skewed  −0.0001 −0.0012 0.0001  .9530 .9440 .9680 
  Left Skewed  −0.0009 −0.0013 0.0001  .9480 .9440 .9670 
 500 Uniform  0.0002 −0.0006 0.0002  .9570 .9500 .9670 
  Right Skewed  0.0005 −0.0007 0.0002  .9570 .9550 .9680 
  Left Skewed  0.0000 −0.0007 0.0001  .9550 .9520 .9660 
 2,000 Uniform  −0.0010 −0.0002 −0.0002  .9440 .9530 .9690 
  Right Skewed  −0.0008 −0.0002 −0.0003  .9440 .9560 .9690 
  Left Skewed  −0.0011 −0.0003 −0.0002  .9440 .9500 .9690 
Note. Whereas the intent-to-treat effect was the estimand for the intent-to-treat method, the dose-response effect was the 
estimand for the confounder adjustment and instrumental variable methods.  Standardized bias never exceeded |0.40| 
(results not shown in table). 
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Table 4 
Study 1 Confidence Interval Width, Type I Error Rate, and Power for Intent-to-Treat, Confounder Adjustment, and 
Instrumental Variable Methods 
Condition  Confidence Interval Width  Type I Error Rate or Power 
Dose-Response 
Effect 
Sample 
Size 
Adherence 
Distribution 
 
Intent-
to-Treat 
Confounder 
Adjustment 
Instrumental 
Variable 
 
Intent-
to-Treat 
Confounder 
Adjustment 
Instrumental 
Variable 
Zero 200 Uniform  0.5568 0.1529 0.0985  .0450 .0550 .0500 
  Right Skewed  0.5568 0.1529 0.1171  .0450 .0560 .0500 
  Left Skewed  0.5568 0.1531 0.0851  .0450 .0560 .0500 
 500 Uniform  0.3515 0.0964 0.0622  .0440 .0500 .0530 
  Right Skewed  0.3515 0.0964 0.0738  .0440 .0450 .0530 
  Left Skewed  0.3515 0.0964 0.0537  .0440 .0480 .0530 
 2,000 Uniform  0.1755 0.0480 0.0310  .0570 .0470 .0470 
  Right Skewed  0.1755 0.0480 0.0368  .0570 .0440 .0470 
  Left Skewed  0.1755 0.0480 0.0268  .0570 .0500 .0470 
Weak 200 Uniform  0.5567 0.1522 0.0982  .1770 .1830 .3440 
  Right Skewed  0.5567 0.1521 0.1168  .1470 .1670 .2590 
  Left Skewed  0.5567 0.1523 0.0848  .2290 .1720 .4340 
 500 Uniform  0.3515 0.0959 0.0620  .4130 .3470 .7050 
  Right Skewed  0.3515 0.0959 0.0736  .3130 .3280 .5540 
  Left Skewed  0.3515 0.0959 0.0536  .5170 .3460 .8230 
 2,000 Uniform  0.1755 0.0478 0.0310  .9280 .8840 .9990 
  Right Skewed  0.1755 0.0478 0.0367  .8230 .8790 .9840 
  Left Skewed  0.1755 0.0478 0.0267  .9730 .8900 1.0000 
Moderate 200 Uniform  0.5565 0.1459 0.0963  .8990 .8640 .9990 
  Right Skewed  0.5565 0.1458 0.1144  .7840 .8700 .9710 
  Left Skewed  0.5564 0.1460 0.0831  .9680 .8730 1.0000 
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 500 Uniform  0.3514 0.0920 0.0608  1.0000 .9990 1.0000 
  Right Skewed  0.3514 0.0919 0.0721  .9930 .9990 1.0000 
  Left Skewed  0.3514 0.0920 0.0525  1.0000 .9990 1.0000 
 2,000 Uniform  0.1754 0.0458 0.0303  1.0000 1.0000 1.0000 
  Right Skewed  0.1754 0.0458 0.0360  1.0000 1.0000 1.0000 
  Left Skewed  0.1754 0.0458 0.0262  1.0000 1.0000 1.0000 
Strong 200 Uniform  0.5564 0.1325 0.0922  1.0000 1.0000 1.0000 
  Right Skewed  0.5564 0.1324 0.1095  .9950 1.0000 1.0000 
  Left Skewed  0.5562 0.1326 0.0796  1.0000 1.0000 1.0000 
 500 Uniform  0.3513 0.0835 0.0582  1.0000 1.0000 1.0000 
  Right Skewed  0.3513 0.0835 0.0690  1.0000 1.0000 1.0000 
  Left Skewed  0.3513 0.0835 0.0502  1.0000 1.0000 1.0000 
 2,000 Uniform  0.1754 0.0416 0.0290  1.0000 1.0000 1.0000 
  Right Skewed  0.1754 0.0416 0.0344  1.0000 1.0000 1.0000 
  Left Skewed  0.1754 0.0416 0.0251  1.0000 1.0000 1.0000 
Note. Whereas the intent-to-treat effect was the estimand for the intent-to-treat method, the dose-response effect was the 
estimand for the confounder adjustment and instrumental variable methods. 
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Table 5 
Study 2 Bias and Confidence Interval Coverage for Intent-to-Treat, Confounder Adjustment, and Instrumental Variable 
Methods 
Condition  Bias  Confidence Interval Coverage 
Unobserved 
Confounding 
Exclusion Restriction 
Violation 
 
Intent-
to-Treat 
Confounder 
Adjustment 
Instrumental 
Variable 
 
Intent-
to-Treat 
Confounder 
Adjustment 
Instrumental 
Variable 
Absent Absent  −0.0007 −0.0004 0.0000  .9583 .9570 .9615 
 Weak  −0.0007 −0.0004 0.0500  .9583 .9570 .0000 
 Moderate  −0.0007 −0.0004 0.1251  .9583 .9570 .0000 
Weak Absent  −0.0007 0.0026 0.0000  .9563 .9570 .9595 
 Weak  −0.0007 0.0026 0.0500  .9563 .9570 .0000 
 Moderate  −0.0007 0.0026 0.1251  .9563 .9570 .0000 
Moderate Absent  −0.0008 0.0283 0.0000  .9578 .3435 .9578 
 Weak  −0.0008 0.0283 0.0500  .9578 .3435 .0000 
 Moderate  −0.0008 0.0283 0.1251  .9578 .3435 .0000 
Strong Absent  −0.0008 0.0962 −0.0001  .9575 .0000 .9520 
 Weak  −0.0008 0.0962 0.0500  .9575 .0000 .0000 
 Moderate  −0.0008 0.0962 0.1250  .9575 .0000 .0000 
Note. The results in this table were averaged across strength of the dose-response effect (zero, weak, moderate, strong).  
Standardized bias exceeded |0.40| for the shaded cells in the “Bias” columns. 
 
 63 
 
 
 
Figure 1. Study 1 uniform, right skewed, and left skewed adherence distributions. 
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Figure 2. Study 2 trellis plot of bias by unobserved confounding and violation of the 
exclusion restriction (abbreviated “ER”).  Whereas the intent-to-treat effect was the 
estimand for the intent-to-treat method, the dose-response effect was the estimand for the 
confounder adjustment and instrumental variable methods.  
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 In this appendix, I describe omitted variable bias in equations.  Suppose that the 
population model for some outcome 𝑌𝑖 is 
 𝑌𝑖 = 𝑏0 + 𝑏1𝐷𝑖 + 𝑏2𝑋𝑖 + 𝜀𝑖 (A1) 
and that 𝑏1 is the regression coefficient of interest.  Further suppose that 𝐷𝑖 and 𝑋𝑖 are 
linearly related as follows: 
 𝑋𝑖 = 𝑔0 + 𝑔1𝐷𝑖 + 𝛿𝑖 (A2) 
and that data on 𝑋𝑖 are unavailable.  Substituting Equation A2 into Equation A1 yields 
the following: 
 𝑌𝑖 = 𝑏0 + 𝑏1𝐷𝑖 + 𝑏2(𝑔0 + 𝑔1𝐷𝑖 + 𝛿𝑖) + 𝜀𝑖. (A3) 
Collecting like terms in Equation A3 yields 
 𝑌𝑖 = (𝑏0 + 𝑏2𝑔0) + (𝑏1 + 𝑏2𝑔1)𝐷𝑖 + (𝜀𝑖 + 𝑏2𝛿𝑖) (A4) 
where (𝑏0 + 𝑏2𝑔0) is the intercept, (𝑏1 + 𝑏2𝑔1) is the regression coefficient for 𝐷𝑖, and 
(𝜀𝑖 + 𝑏2𝛿𝑖) is the residual. 
 When omitting 𝑋𝑖 from Equation A1, the regression coefficient estimated for 𝐷𝑖 
equals (𝑏1 + 𝑏2𝑔1) as in Equation A4 instead of 𝑏1 as in Equation A1.  The term 𝑏2𝑔1 
represents bias due to omitting 𝑋𝑖 (see Equation 3 in McCallum, 1972).  In this example, 
the estimated regression coefficient will be unbiased if 𝑋𝑖 either is unrelated to 𝑌𝑖 (i.e., 
𝑏2 = 0) or is unrelated to 𝐷𝑖 (i.e., 𝑔1 = 0) such that 𝑏2𝑔1 = 0.  The estimated regression 
coefficient will be positively biased when 𝑏2 and 𝑔1 have the same sign (i.e., are both 
positive or both negative) and will be negatively biased when 𝑏2 and 𝑔1 have opposite 
signs.  
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Simulation Study 1 
 To generate the outcome in the treatment condition, values of the unstandardized 
regression coefficient 𝑏1 in Equation 6 were calculated based on the following equation: 
 𝑏1 = 𝜌𝑌𝐷 (
𝜎𝑌
𝜎𝐷
)  (B1) 
where 𝜌𝑌𝐷 is the correlation between 𝐷𝑖 and 𝑌𝑖, 𝜎𝑌 = 1.0000 is the standard deviation of 
𝑌𝑖, and 𝜎𝐷 is the standard deviation of 𝐷𝑖.  The standard deviation of 𝐷𝑖 equaled 2.5820 
for conditions with a uniform adherence distribution and 2.5832 for conditions with a 
(right or left) skewed adherence distribution.  Values of the residual variance 𝜎𝜀
2 were 
calculated based on the following equation: 
 𝜎𝜀
2 = (1 − 𝑅2)𝜎𝑌
2 = (1 − 𝜌𝑌𝐷
2 )𝜎𝑌
2 (B2) 
where 𝜎𝑌 = 1.0000 is the standard deviation of 𝑌𝑖 and 𝜌𝑌𝐷 is the correlation between 𝐷𝑖 
and 𝑌𝑖.  Based on Equations B1 and B2, the specified values of the unstandardized 
regression coefficient and residual variance in Equation 6 were 𝑏1 = 0.0000 and 
𝜎𝜀
2 = 1.0000, 𝑏1 = 0.0387 and 𝜎𝜀
2 = 0.9900, 𝑏1 = 0.1162 and 𝜎𝜀
2 = 0.9100, or 
𝑏1 = 0.1936 and 𝜎𝜀
2 = 0.7500 to achieve a zero, weak, moderate, or strong dose-
response effect. 
Simulation Study 2 
 To generate the outcome in the treatment condition, values of the unstandardized 
regression coefficients 𝑏1 and 𝑏2 in Equation 7 were calculated based on the following 
equations: 
 𝑏1 = 𝛽1 (
𝜎𝑌
𝜎𝐷
) = (
𝜌𝑌𝐷 − 𝜌𝑌𝑈𝜌𝐷𝑈
1 − 𝜌𝐷𝑈
2 ) (
𝜎𝑌
𝜎𝐷
) (B3) 
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 𝑏2 = 𝛽2 (
𝜎𝑌
𝜎𝑈
) = (
𝜌𝑌𝑈 − 𝜌𝑌𝐷𝜌𝐷𝑈
1 − 𝜌𝐷𝑈
2 ) (
𝜎𝑌
𝜎𝑈
) (B4) 
where 𝛽1 and 𝛽2 are the standardized regression coefficients for 𝐷𝑖 and 𝑈𝑖, respectively; 
𝜎𝑌 = 1.0000, 𝜎𝐷 = 2.5820, and 𝜎𝑈 = 1.0000 are the standard deviations of 𝑌𝑖, 𝐷𝑖, and 
𝑈𝑖, respectively; 𝜌𝑌𝐷 is the correlation between 𝐷𝑖 and 𝑌𝑖; 𝜌𝑌𝑈 is the correlation between 
𝑈𝑖 and 𝑌𝑖; and 𝜌𝐷𝑈 is the correlation between 𝐷𝑖 and 𝑈𝑖 (see Equation 3.2.4 in Cohen, 
Cohen, West, & Aiken, 2003).  The intercept 𝑏0 in Equation 7 was set to 0.00, 0.20, or 
0.50, where nonzero values represent violations of the exclusion restriction.  These values 
correspond to standardized mean differences of 𝛿 = 0.00, 0.20, or 0.50, respectively, 
because the variance of 𝑌𝑖 was set to one in both the treatment and control conditions.  
Values of the residual variance 𝜎𝜀
2 were calculated based on the following equation: 
 𝜎𝜀
2 = (1 − 𝑅2)𝜎𝑌
2 = [1 − (𝛽1𝜌𝑌𝐷 + 𝛽2𝜌𝑌𝑈)]𝜎𝑌
2 (B5) 
where 𝜎𝑌 = 1.0000 is the standard deviation of 𝑌𝑖; 𝛽1 and 𝛽2 are the standardized 
regression coefficients for 𝐷𝑖 and 𝑈𝑖, respectively (see Equations B3 and B4); 𝜌𝑌𝐷 is the 
correlation between 𝐷𝑖 and 𝑌𝑖; and 𝜌𝑌𝑈 is the correlation between 𝑈𝑖 and 𝑌𝑖 (see Equation 
3.5.3 for 𝑅2 in Cohen et al., 2003).  The specified values of the unstandardized regression 
coefficients and residual variance under each condition are summarized in Table B1. 
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Table B1 
Study 2 Specified Values of Unstandardized Regression Coefficients and Residual Variance to Generate 𝑌𝑖 in 
Treatment Condition 
Manipulated Factors  Specified Values in Equation 7 
Dose-Response 
Effect 
 
Unobserved 
Confounding 
 
Regression Coefficient 
for 𝐷𝑖 
 
Regression Coefficient 
for 𝑈𝑖 
 
Residual 
Variance 
Zero 
 Absent  0.0000  0.0000  1.0000 
 Weak  −0.0039  0.1010  0.9899 
 Moderate  −0.0383  0.3297  0.9011 
 Strong  −0.1291  0.6667  0.6667 
Weak 
 Absent  0.0387  0.0000  0.9900 
 Weak  0.0352  0.0909  0.9818 
 Moderate  0.0043  0.2967  0.9099 
 Strong  −0.0775  0.6000  0.7200 
Moderate 
 Absent  0.1162  0.0000  0.9100 
 Weak  0.1135  0.0707  0.9051 
 Moderate  0.0894  0.2308  0.8615 
 Strong  0.0258  0.4667  0.7467 
Strong 
 Absent  0.1936  0.0000  0.7500 
 Weak  0.1917  0.0505  0.7475 
 Moderate  0.1745  0.1648  0.7253 
 Strong  0.1291  0.3333  0.6667 
 
 71 
APPENDIX C 
SAS 9.4 CODE FOR INTENT-TO-TREAT, CONFOUNDER ADJUSTMENT, AND 
INSTRUMENTAL VARIABLE METHODS 
  
 72 
/* Intent-to-Treat Method */ 
 
PROC REG DATA = example_data; 
 MODEL Y = Z; 
RUN; 
 
 
/* Confounder Adjustment Method */ 
 
PROC REG DATA = example_data; 
 MODEL Y = D; 
 WHERE Z = 1; /* Select cases in the treatment condition. */ 
RUN; 
 
 
/* Instrumental Variable Method */ 
 
PROC SYSLIN DATA = example_data FIRST 2SLS; 
 ENDOGENOUS D; 
 INSTRUMENTS Z; 
 equation: MODEL Y = D / NOINT; 
RUN; 
 
